These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 15720784

  • 1. In-vivo effects of the 1,2,4-piperazine derivatives MM5 and MC1, putative 5-HT agonists, on dopamine and serotonin release in rat prefrontal cortex.
    Iskra-Jopa J, Gołembiowska K, Dziubina A, Cybulski M, Duszyńska B, Chilmonczyk Z.
    J Pharm Pharmacol; 2005 Feb; 57(2):205-11. PubMed ID: 15720784
    [Abstract] [Full Text] [Related]

  • 2. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB, Ravailhe V, Faucillon V, Newman-Tancredi A.
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM, Lésourd M, Artigas F.
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [Abstract] [Full Text] [Related]

  • 5. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J, Meltzer HY.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [Abstract] [Full Text] [Related]

  • 6. Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.
    Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T.
    Eur J Pharmacol; 2007 Mar 22; 559(2-3):155-60. PubMed ID: 17258195
    [Abstract] [Full Text] [Related]

  • 7. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 8. Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.
    Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.
    Br J Pharmacol; 2004 Jun 12; 142(3):469-78. PubMed ID: 15148253
    [Abstract] [Full Text] [Related]

  • 9. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
    Solati J, Salari AA, Bakhtiari A.
    Neurosci Lett; 2011 Oct 31; 504(3):325-9. PubMed ID: 21982809
    [Abstract] [Full Text] [Related]

  • 10. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M, Zhang L, Rotondo A, Sun H, Morales M.
    Synapse; 2003 Dec 15; 50(4):303-13. PubMed ID: 14556235
    [Abstract] [Full Text] [Related]

  • 11. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors.
    Invernizzi RW, Sacchetti G, Parini S, Acconcia S, Samanin R.
    Br J Pharmacol; 2003 Aug 15; 139(7):1281-8. PubMed ID: 12890707
    [Abstract] [Full Text] [Related]

  • 12. 5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine.
    Rasmusson AM, Goldstein LE, Deutch AY, Bunney BS, Roth RH.
    Synapse; 1994 Nov 15; 18(3):218-24. PubMed ID: 7855734
    [Abstract] [Full Text] [Related]

  • 13. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
    Przegaliński E, Filip M, Bijak M, Wedzony K, Budziszewska B, Tokarski K, Maćkowiak M, Fijał K.
    Pol J Pharmacol; 1996 Nov 15; 48(1):13-22. PubMed ID: 9112623
    [Abstract] [Full Text] [Related]

  • 14. Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.
    Nakayama K, Sakurai T, Katsu H.
    Brain Res Bull; 2004 Apr 30; 63(3):237-41. PubMed ID: 15145142
    [Abstract] [Full Text] [Related]

  • 15. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat.
    Adell A, Artigas F.
    Br J Pharmacol; 1998 Nov 30; 125(6):1361-7. PubMed ID: 9863668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul 30; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 19. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD.
    J Med Chem; 1998 Apr 09; 41(8):1218-35. PubMed ID: 9548813
    [Abstract] [Full Text] [Related]

  • 20. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T.
    Eur J Pharmacol; 2005 Jul 11; 517(3):165-73. PubMed ID: 15985260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.